Revenue Recognition and Accounts Receivable - Schedule of Net Sales by Product Category by Reporting Segment (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenue Recognition And Accounts Receivable [Line Items]
Net sales	$ 198,620	$ 187,016	$ 387,228	$ 362,220
Change	6.20%		6.90%
Bone Growth Therapies [Member]
Revenue Recognition And Accounts Receivable [Line Items]
Net sales	$ 59,135	52,662	$ 111,612	100,376
Change	12.30%		11.20%
Spinal Implants, Biologics, and Enabling Technologies [Member]
Revenue Recognition And Accounts Receivable [Line Items]
Net sales	$ 108,899	105,314	$ 217,715	206,806
Change	3.40%		5.30%
Global Spine [Member]
Revenue Recognition And Accounts Receivable [Line Items]
Net sales	$ 168,034	157,976	$ 329,327	307,182
Change	6.40%		7.20%
Global Orthopedics [Member]
Revenue Recognition And Accounts Receivable [Line Items]
Net sales	$ 30,586	$ 29,040	$ 57,901	$ 55,038
Change	5.30%		5.20%